TOI, Y.; KIMURA, Y.; DOMEKI, Y.; KAWANA, S.; AIBA, T.; ONO, H.; ASOU, M.; TSURUMI, K.; SUZUKI, K.; SHIMIZU, H.; SUGISAKA, J.; SAITO, R.; TERAYAMA, K.; KAWASHIMA, Y.; NAKAMURA, A.; YAMANDA, S.; HONDA, Y.; SUGAWARA, S. Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study. Sarcoidosis vasculitis and diffuse lung disease, v. 36, n. 1, p. 74-78, 11 Mar. 2019.